Future Internet Social and Technological Alignment Research (FISTAR)

October 4, 2016 updated by: Ana María González-Pinto, Basque Health Service

Future Internet Social and Technological Alignment Research (FISTAR)

Bipolar disorder patients frequently presents recurring episodes and often experience subsyndromal symptoms, cognitive impairment and difficulties in the functioning with a low quality of life, relapses of disease and recurring hospitalization. Early diagnosis and appropriate intervention may play a role in preventing the neuroprogressive course of bipolar illness. The new technologies represent an opportunity to develop psychological standardized treatments using internet devices that minimizing the limitations of face to face treatments because of its accessibility that allow adjusting to the availability of each user. However, although exist many online psychological programs through web and mobile devices for bipolar disorder, there is not evidence about their efficacy and effectiveness due to the variability in measures and methodology used.

Study Overview

Status

Completed

Conditions

Detailed Description

Future Internet Social and Technological Alignment Research (FI-STAR) clinical trial is a randomized simple blind evaluation within an European project. FISTAR is developed to compare this technical solution with treatment as usual. Bipolar disorder patients are to be included and randomly assigned to one of two treatment groups: 1) the experimental group (tele-care support) and the control group. Participants in both groups will be evaluated at baseline (pre-treatment) and at post-treatment.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Having a diagnosis of bipolar disorder.
  • Being aged between 18-50 years.
  • Being in remission (euthymic state).
  • Being familiarity with new technologies (computer and /or smartphone).
  • Being treatment in the mental health network of the Basque Country (Osakidetza).

Exclusion Criteria:

  • Having listening, reading or writing problems.
  • Having a diagnosis of mental retardation.
  • Unavailability of a smartphone.
  • Having manic or depressive symptomatology at the time of inclusion (HAMD> 16 and YOUNG> 8).
  • Having suicidal ideation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tele-care support
Online psychoeducation treatment using new technologies
Psychoeducation treatment based on telemedicine
Active Comparator: Control group
Standard care
Standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functioning Assessment Short Test (FAST)
Time Frame: baseline-9 weeks
To analyze the effectiveness of a psychoeducation treatment based on telemedicine versus usual treatment in relation with better functional outcome of bipolar disorder measured by Functioning Assessment Short Test.
baseline-9 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Beck Depression Inventory (BDI-II)
Time Frame: baseline-9 weeks
To analyze the improvement of depressive symptoms of patients measured by Beck Depression Inventory .
baseline-9 weeks
State-Trait Anxiety Inventory (STAI)
Time Frame: baseline-9 weeks
To analyze the improvement of anxiety symptoms of patients measured by State-Trait Anxiety Inventory .
baseline-9 weeks
Young Mania Rating Scale (YMRS)
Time Frame: baseline-9 weeks
To analyze the improvement of manic symptoms of patients measured by Young Mania Rating Scale .
baseline-9 weeks
Treatment dropout rate
Time Frame: baseline-9 weeks
To analyze satisfaction with the treatment received and the contact with the health service by treatment dropout rate.
baseline-9 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ana González-Pinto, MD, ANAMARIA.GONZALEZ-PINTOARRILLAGA@osakidetza.eus

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2013

Primary Completion (Actual)

December 1, 2015

Study Completion (Actual)

December 1, 2015

Study Registration Dates

First Submitted

September 27, 2016

First Submitted That Met QC Criteria

October 4, 2016

First Posted (Estimate)

October 5, 2016

Study Record Updates

Last Update Posted (Estimate)

October 5, 2016

Last Update Submitted That Met QC Criteria

October 4, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • FISTAR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Bipolar Disorder

Clinical Trials on Tele-care support

3
Subscribe